Wednesday, November 4, 2020

Promising COVID-19 Treatment and Big Pharma

Drug Prices are Too High

Finally! A new treatment, Remdesivir, is showing promise against COVID. But pharma giant Gilead Sciences is putting the price out of reach for most Americans - over $3,000 per patient! American taxpayers already put $70 billion into this. Is that fair? 

 

Gilead   Sciences

 

TAKE ACTION

*By answering this survey, you are subscribing to my newsletter.

E-mail Updates

Yes, please periodically send me e-mail updates.*

Click Here

*By subscribing to my e-mail updates, you are authorizing me to send regular e-mail updates from my office to your e-mail account.

Contact Information
Address: P.O. Box 27380 | Washington D.C., 20038-7380
Paid for by Social Security Works

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.